Annual Operating Expenses
$8.94 M
-$1.97 M-18.05%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual total operating expenses is $8.94 million, with the most recent change of -$1.97 million (-18.05%) on December 31, 2023.
- During the last 3 years, CANF annual operating expenses has fallen by -$5.96 million (-40.02%).
- CANF annual operating expenses is now -40.02% below its all-time high of $14.90 million, reached on December 31, 2020.
Performance
CANF Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
N/A
June 30, 2024
Summary
- CANF quarterly total operating expenses is not available.
Performance
CANF Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CANF Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.1% | - |
| 3 y3 years | -40.0% | - |
| 5 y5 years | -3.2% | - |
CANF Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.7% | at low | ||
| 5 y | 5-year | -40.0% | at low | ||
| alltime | all time | -40.0% | +98.2% |
Can-Fite BioPharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $8.94 M(-18.0%) | $1.99 M(-3.5%) |
| Sep 2023 | - | $2.06 M(+4.1%) |
| Jun 2023 | - | $1.98 M(-31.9%) |
| Mar 2023 | - | $2.91 M(-11.3%) |
| Dec 2022 | $10.91 M(-20.4%) | $3.28 M(+18.1%) |
| Sep 2022 | - | $2.78 M(+22.1%) |
| Jun 2022 | - | $2.27 M(-11.7%) |
| Mar 2022 | - | $2.58 M(-39.2%) |
| Dec 2021 | $13.70 M(-8.1%) | $4.23 M(+12.5%) |
| Sep 2021 | - | $3.76 M(+11.2%) |
| Jun 2021 | - | $3.38 M(+45.9%) |
| Mar 2021 | - | $2.32 M(-37.4%) |
| Dec 2020 | $14.90 M(+6.1%) | $3.70 M(+37.7%) |
| Sep 2020 | - | $2.69 M(-33.3%) |
| Jun 2020 | - | $4.04 M(-9.8%) |
| Mar 2020 | - | $4.47 M(-6.8%) |
| Dec 2019 | $14.04 M(+52.0%) | - |
| Dec 2019 | - | $4.80 M(+21.8%) |
| Sep 2019 | - | $3.94 M(+20.1%) |
| Jun 2019 | - | $3.28 M(+63.3%) |
| Mar 2019 | - | $2.01 M(-28.0%) |
| Dec 2018 | $9.23 M(+15.8%) | - |
| Dec 2018 | - | $2.79 M(+40.7%) |
| Sep 2018 | - | $1.99 M(-11.3%) |
| Jun 2018 | - | $2.24 M(+0.8%) |
| Mar 2018 | - | $2.22 M(-5.8%) |
| Dec 2017 | $7.97 M(-9.9%) | - |
| Dec 2017 | - | $2.36 M(+30.4%) |
| Sep 2017 | - | $1.81 M(-1.0%) |
| Jun 2017 | - | $1.83 M(-7.8%) |
| Mar 2017 | - | $1.98 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $8.85 M(+34.5%) | - |
| Dec 2016 | - | $2.63 M(+13.0%) |
| Sep 2016 | - | $2.33 M(+7.1%) |
| Jun 2016 | - | $2.18 M(+27.8%) |
| Mar 2016 | - | $1.70 M(-29.4%) |
| Dec 2015 | $6.58 M(-7.7%) | - |
| Dec 2015 | - | $2.41 M(+71.1%) |
| Sep 2015 | - | $1.41 M(-8.6%) |
| Jun 2015 | - | $1.54 M(+27.1%) |
| Mar 2015 | - | $1.21 M(-26.8%) |
| Dec 2014 | $7.13 M(-20.7%) | - |
| Dec 2014 | - | $1.66 M(+20.6%) |
| Sep 2014 | - | $1.38 M(-36.4%) |
| Jun 2014 | - | $2.16 M(+11.9%) |
| Mar 2014 | - | $1.93 M(-43.9%) |
| Dec 2013 | $8.99 M(+49.7%) | $3.44 M(+122.0%) |
| Sep 2013 | - | $1.55 M(-28.9%) |
| Jun 2013 | - | $2.18 M(+26.7%) |
| Mar 2013 | - | $1.72 M(-18.1%) |
| Dec 2012 | $6.00 M(+14.8%) | - |
| Dec 2012 | - | $2.10 M(+75.4%) |
| Sep 2012 | - | $1.20 M(-4.0%) |
| Jun 2012 | - | $1.25 M(-20.0%) |
| Mar 2012 | - | $1.56 M(+24.5%) |
| Dec 2011 | $5.23 M(+16.0%) | - |
| Dec 2011 | - | $1.26 M(+7.4%) |
| Sep 2011 | - | $1.17 M(-16.1%) |
| Jun 2011 | - | $1.39 M(-14.9%) |
| Mar 2011 | - | $1.64 M(+28.6%) |
| Dec 2010 | $4.51 M | - |
| Dec 2010 | - | $1.27 M(+27.1%) |
| Sep 2010 | - | $1.00 M |
FAQ
- What is Can-Fite BioPharma annual total operating expenses?
- What is the all time high annual operating expenses for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual operating expenses year-on-year change?
- What is the all time high quarterly operating expenses for Can-Fite BioPharma?
What is Can-Fite BioPharma annual total operating expenses?
The current annual operating expenses of CANF is $8.94 M
What is the all time high annual operating expenses for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual total operating expenses is $14.90 M
What is Can-Fite BioPharma annual operating expenses year-on-year change?
Over the past year, CANF annual total operating expenses has changed by -$1.97 M (-18.05%)
What is the all time high quarterly operating expenses for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly total operating expenses is $4.80 M